CD8A and non-small cell lung carcinoma: Firstly, we quantitatively assessed PD-L1, CD8 and IFN-γ gene expression by using RT-qPCR in NSCLC fresh tumor samples as a validation cohort, apart from common semi-quantitative immunohistochemistry.